Fristrup N, Ulhøi BP, Birkenkamp-Demtröder K, Mansilla F, Sanchez-Carbayo M, Segersten U, Malmström P-U, Hartmann A, Palou J, Alvarez-Múgica M, et al. 2012.
Cathepsin E, maspin, Plk1, and survivin are promising prognostic protein markers for progression in non-muscle invasive bladder cancer.
American Journal of Pathology. 180(5):1824-34.
https://doi.org/10.1016/j.ajpath.2012.01.023
Laurberg JR, Brems-Eskildsen AS, Nordentoft I, Fristrup N, Schepeler T, Ulhøi BP, Agerbaek M, Hartmann A, Bertz S, Wittlinger M, et al. 2012.
Expression of TIP60 (tat-interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment-specific outcome of localised invasive bladder cancer.
B J U International (Online).
https://doi.org/10.1111/j.1464-410X.2012.11564.x
Andresen BS, Lund AM, Hougaard DM, Christensen E, Gahrn B
, Christensen M, Bross P, Vested A, Simonsen H, Skogstrand K, et al. 2012.
MCAD deficiency in Denmark.
Molecular Genetics and Metabolism. 106(2):175-88.
https://doi.org/10.1016/j.ymgme.2012.03.018
Villadsen SB, Bramsen JB, Ostenfeld MS, Wiklund ED, Fristrup N, Gao S, Hansen TB, Jensen TI, Borre M, Orntoft TF, et al. 2012.
The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer.
B J C. 106(2):366-374.
https://doi.org/10.1038/bjc.2011.520
Munksgaard PP
, Mansilla F, Brems Eskildsen A-S
, Fristrup N, Birkenkamp-Demtröder K, Ulhøi BP, Borre M, Agerbæk M, Hermann GG
, Orntoft TF, et al. 2011.
Low ANXA10 expression is associated with disease aggressiveness in bladder cancer.
B J C. 105(9):1379-87.
https://doi.org/10.1038/bjc.2011.404
Ho G, Yonezawa A, Masuda S, Inui K, Sim KG, Carpenter K
, Olsen RK, Mitchell JJ, Rhead WJ, Peters G, et al. 2011.
Maternal riboflavin deficiency,resulting in transient neonatal-onset glutaric aciduria Type 2, is caused by amicrodeletion in the riboflavin transporter gene GPR172B.
Human Mutation. 32/1.
Straadt IK, Young JF, Petersen BO, Duus JØ
, Gregersen N, Bross P, Oksbjerg N, Bertram HCS. 2011.
Metabolic responses to heat, Anoxia, or oxidative stress elucidated in muscle cell cultures using 13C NMR spectroscopy. Renou JP, Belton PS, Webb GA, editors. In Magnetic Resonance in Food Science: An exciting future. pp. 118-123.
Larsen JKR, Smerup MH, Nørregaard R, Christensen JH, Sivesgaard K, Christensen SD, Christensen K
, Sloth E, Torp P, Gregersen N, et al. 2011.
Multiplex Analysis of Cardiac Hypertrophic Signaling: Reduced in vivoPhosphorylation of Glycogen Synthase Kinase-3β and Proline-Rich Akt Substrate (PRAS40).
Current Signal Transduction Therapy. 6(1):65-70.
Sykut-Cegielska J, Gradowska W, Piekutowska-Abramczuk D
, Andresen BS, Olsen RKJ, Ołtarzewski M, Pronicki M, Pajdowska M, Bogdańska A, Jabłońska E, et al. 2011.
Urgent metabolic service improves survival in long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency detected by symptomatic identification and pilot newborn screening.
Journal of Inherited Metabolic Disease. 34(1):185-95.
https://doi.org/10.1007/s10545-010-9244-x
Piekutowska-Abramczuk D
, Olsen RKJ, Wierzba J, Popowska E, Jurkiewicz D, Ciara E, Ołtarzewski M, Gradowska W, Sykut-Cegielska J, Krajewska-Walasek M, et al. 2010.
A comprehensive HADHA c.1528G>C frequency study reveals high prevalence of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency in Poland.
Journal of Inherited Metabolic Disease.
https://doi.org/10.1007/s10545-010-9190-7
Piekutowska-Abramczuk D
, Olsen R, Wierzba J, Popowska E, Jurkiewicz D, Ciara E, Ołtarzewski M, Gradowska W, Sykut-Cegielska J, Krajewska-Walasek M, et al. 2010.
A comprehensive HADHA c.1528G>C frequency studyreveals high prevalence of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency in Poland.
Journal of Inherited Metabolic Disease.